Peptic ulcer disease endoscopy: Difference between revisions
Jump to navigation
Jump to search
| Line 28: | Line 28: | ||
{{familytree | | C01 | | | | | C02 | | | | | C03 |C01=Active bleeding<br>or non-bleeding<br> visible vessel |C02=Adherent clot |C03=Flat spot<br> or clean base}} | {{familytree | | C01 | | | | | C02 | | | | | C03 |C01=Active bleeding<br>or non-bleeding<br> visible vessel |C02=Adherent clot |C03=Flat spot<br> or clean base}} | ||
{{familytree | | |!| | | | | | |!| | | | | | |!| |}} | {{familytree | | |!| | | | | | |!| | | | | | |!| |}} | ||
{{familytree | | D01 | | | | | D02 | | | | | D03 |D01=Endoscopic therapies<br> | {{familytree | | D01 | | | | | D02 | | | | | D03 |D01=Endoscopic therapies:<br>•Injection therapy<br>•|D02=D02|D03=D03}} | ||
{{familytree | | |!| | | | | | |!| | | | | | |!|}} | {{familytree | | |!| | | | | | |!| | | | | | |!|}} | ||
{{familytree | | |`|-|-|-|-|-|-|+|-|-|-|-|-|-|'|}} | {{familytree | | |`|-|-|-|-|-|-|+|-|-|-|-|-|-|'|}} | ||
Revision as of 19:42, 7 November 2017
|
Peptic ulcer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
2017 ACG Guidelines for Peptic Ulcer Disease |
|
Guidelines for the Indications to Test for, and to Treat, H. pylori Infection |
|
Guidlines for factors that predict the successful eradication when treating H. pylori infection |
|
Guidelines to document H. pylori antimicrobial resistance in the North America |
|
Guidelines for evaluation and testing of H. pylori antibiotic resistance |
|
Guidelines for when to test for treatment success after H. pylori eradication therapy |
|
Guidelines for penicillin allergy in patients with H. pylori infection |
|
Peptic ulcer disease endoscopy On the Web |
|
American Roentgen Ray Society Images of Peptic ulcer disease endoscopy |
|
Risk calculators and risk factors for Peptic ulcer disease endoscopy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Endoscopic therapy
Indications for endoscopic therapy
- Patients with active spurting or oozing bleeding or a non-bleeding visible vessel[1]
- Patients with an adherent clot resistant to vigorous irrigation
Endoscopic therapy can be done by following methods:[2]
- Injection therapy:
- Thermal coagulation:
- Contact types -heater probe, monopolar and bipolar electrocoagulation
- Noncontact types -laser treatment, argon plasma coagulation [APC][7]
- Mechanical Devices-Endoclips and band ligation are used commonly[8][9]
- Combined Therapy-injection of diluted epinephrine followed by thermal coagulation[7]
- Hemospray: nanopowder with clotting abilities is sprayed onto the bleeding site.[10]
Endoscopic therapy and Medical therapy for bleeding ulcer
| Bleeding ulcer | |||||||||||||||||||||||||||||||||||||
| Endoscopy | |||||||||||||||||||||||||||||||||||||
| Active bleeding or non-bleeding visible vessel | Adherent clot | Flat spot or clean base | |||||||||||||||||||||||||||||||||||
| Endoscopic therapies: •Injection therapy • | D02 | D03 | |||||||||||||||||||||||||||||||||||
| E01 | |||||||||||||||||||||||||||||||||||||
Second look endoscopy
- Second look endoscopy is used to detect and retreat ulcers that are at risk of recurrent bleeding which reduces the number of episodes of recurrent bleeding and hence decrease the surgery necessary to treat recurrent bleeding[11][12]
- It is usually done after 24 hours.
If bleeding occurs after a second endoscopic therapeutic session, surgery or interventional radiology with transcatheter arterial embolization is done.
References
- ↑ Laine L, McQuaid KR (2009). "Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials". Clin. Gastroenterol. Hepatol. 7 (1): 33–47, quiz 1–2. doi:10.1016/j.cgh.2008.08.016. PMID 18986845.
- ↑ Cook DJ, Guyatt GH, Salena BJ, Laine LA (1992). "Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis". Gastroenterology. 102 (1): 139–48. PMID 1530782.
- ↑ Park CH, Lee SJ, Park JH, Park JH, Lee WS, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ (2004). "Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding". Gastrointest. Endosc. 60 (6): 875–80. PMID 15605000.
- ↑ Rutgeerts P, Rauws E, Wara P, Swain P, Hoos A, Solleder E, Halttunen J, Dobrilla G, Richter G, Prassler R (1997). "Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer". Lancet. 350 (9079): 692–6. PMID 9291903.
- ↑ Chung SC, Leong HT, Chan AC, Lau JY, Yung MY, Leung JW, Li AK (1996). "Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial". Gastrointest. Endosc. 43 (6): 591–5. PMID 8781939.
- ↑ Scharnke W, Hust MH, Braun B, Schumm W (1997). "[Complete gastric wall necrosis after endoscopic sclerotherapy for a gastric ulcer with visible arterial stump]". Dtsch. Med. Wochenschr. (in German). 122 (19): 606–9. doi:10.1055/s-2008-1047662. PMID 9182025.
- ↑ 7.0 7.1 Lin HJ, Tseng GY, Perng CL, Lee FY, Chang FY, Lee SD (1999). "Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding". Gut. 44 (5): 715–9. PMC 1727515. PMID 10205211.
- ↑ Ohta S, Yukioka T, Ohta S, Miyagatani Y, Matsuda H, Shimazaki S (1996). "Hemostasis with endoscopic hemoclipping for severe gastrointestinal bleeding in critically ill patients". Am. J. Gastroenterol. 91 (4): 701–4. PMID 8677932.
- ↑ Scapa E (1997). "Treating gastrointestinal bleeding with endoscopic hemoclips". Surg Laparosc Endosc. 7 (2): 94–6. PMID 9109234.
- ↑ Sung JJ, Luo D, Wu JC, Ching JY, Chan FK, Lau JY, Mack S, Ducharme R, Okolo P, Canto M, Kalloo A, Giday SA (2011). "Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding". Endoscopy. 43 (4): 291–5. doi:10.1055/s-0030-1256311. PMID 21455870.
- ↑ Chiu PW, Lam CY, Lee SW, Kwong KH, Lam SH, Lee DT, Kwok SP (2003). "Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial". Gut. 52 (10): 1403–7. PMC 1773815. PMID 12970130.
- ↑ Villanueva C, Balanzó J, Torras X, Soriano G, Sáinz S, Vilardell F (1994). "Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial". Gastrointest. Endosc. 40 (1): 34–9. PMID 8163132.